Most Popular Stories
- Ben Venue can't say when crucial cancer drug will be available
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- Novartis dealt another setback to broader Menveo use
- The best of times, the worst of times?
- Pioneering stem cell therapy mends damaged heart tissue in patients
- Karo Bio walks away from Phase III cholesterol drug due to safety risks
- Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
- Pioneering stem cell therapy mends damaged heart tissue in patients
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
Webinars
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
Featured Jobs
-
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA
Events
- Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Pharmaceutical Strategic Outlook
April 11-13, 2012 - Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York - Just Released: New Trends in Preventive and Therapeutic Vaccine
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Otava Lead-Like Library
- Avoiding Post-Acquisition Product Sales Failures
- Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
- Failing to Establish and Maintain CAPA Systems? Your Company Could Be At Risk.
- Retaining Brand Loyalty
Ironwood Pharmaceuticals CEO Peter M. Hecht, Ph.D.
